WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010030783) METHODS FOR THE ADMINISTRATION OF ILOPERIDONE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/030783    International Application No.:    PCT/US2009/056517
Publication Date: 18.03.2010 International Filing Date: 10.09.2009
IPC:
A61K 31/454 (2006.01), A61K 31/4525 (2006.01), A61K 31/439 (2006.01), A61K 31/137 (2006.01), A61K 31/138 (2006.01), A61P 25/00 (2006.01), A61P 25/18 (2006.01), A61P 25/24 (2006.01), A61K 49/00 (2006.01), G01N 33/50 (2006.01)
Applicants: VANDA PHARMACEUTICALS, INC. [US/US]; 9605 Medical Center Drive, Suite 300 Rockville, MD 20850 (US) (For All Designated States Except US).
WOLFGANG, Curt [US/US]; (US) (For US Only).
POLYMEROPOULOS, Mihael [US/US]; (US) (For US Only).
LAVEDAN, Christian [US/US]; (US) (For US Only).
VOLPI, Simona [IT/US]; (US) (For US Only)
Inventors: WOLFGANG, Curt; (US).
POLYMEROPOULOS, Mihael; (US).
LAVEDAN, Christian; (US).
VOLPI, Simona; (US)
Agent: TORELLI, Jayme, M.; Hoffman Warnick LLC 75 State Street, 14th Floor Albany, NY 12207 (US)
Priority Data:
12/208,027 10.09.2008 US
Title (EN) METHODS FOR THE ADMINISTRATION OF ILOPERIDONE
(FR) MÉTHODES D'ADMINISTRATION D'ILOPÉRIDONE
Abstract: front page image
(EN)The present invention relates to methods for the identification of genetic polymorphisms that may be associated with a risk for QT prolongation after treatment with iloperidone and related methods of administering iloperidone to patients with such polymorphisms.
(FR)La présente invention porte sur des procédés permettant l'identification de polymorphismes génétiques qui peuvent être associés à un risque pour un allongement du QT après traitement à l'ilopéridone et sur des méthodes correspondantes d'administration d'ilopéridone à des patients présentant de tels polymorphismes.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)